Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog October 9, 2014
Two new studies reveal the processes in our cells that cause lung cancers develop – a process that can take more than twenty years.
Category: Science Blog September 10, 2014
We speak to our pancreatic cancer expert Professor Andrew Biankin about how he’s trying to change the picture for people with the disease.
Category: Science Blog July 25, 2014
To coincide with the publication of our Annual Review, here are some of the key research milestones that our amazing supporters have helped fund.